Violation Tracker Individual Record
Date:October 22, 2008
Offense Group:healthcare-related offenses
Primary Offense:off-label or unapproved promotion of medical products
Secondary Offense:consumer protection violation
Pfizer agreed to pay $60 million to settle multistate litigation alleging that it engaged in unfair and deceptive practices in marketing its second-generation pain reliever, Bextra, for unapproved off-label uses.
Level of Government:state
Action Type:agency action
Agency:Multistate Attorneys General Case
Civil or Criminal Case:civil
HQ Country of Parent:USA
HQ State of Parent:New York
Ownership Structure of Parent:publicly traded
Major Industry of Parent:pharmaceuticals
Specific Industry of Parent:pharmaceuticals
Source Notes:If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.